AU2972199A - Apoptosis inducing molecule ii and methods of use - Google Patents

Apoptosis inducing molecule ii and methods of use

Info

Publication number
AU2972199A
AU2972199A AU29721/99A AU2972199A AU2972199A AU 2972199 A AU2972199 A AU 2972199A AU 29721/99 A AU29721/99 A AU 29721/99A AU 2972199 A AU2972199 A AU 2972199A AU 2972199 A AU2972199 A AU 2972199A
Authority
AU
Australia
Prior art keywords
methods
apoptosis inducing
inducing molecule
molecule
apoptosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29721/99A
Inventor
Reinhard Ebner
Steven M. Ruben
Stephen Ullrich
Guo-Liang Yu
Yifan Zhai
Jun Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/027,287 external-priority patent/US6479254B2/en
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of AU2972199A publication Critical patent/AU2972199A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU29721/99A 1998-02-20 1999-02-19 Apoptosis inducing molecule ii and methods of use Abandoned AU2972199A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US7540998P 1998-02-20 1998-02-20
US60075409 1998-02-20
US09/027,287 US6479254B2 (en) 1996-03-22 1998-02-20 Apoptosis inducing molecule II
US09027287 1998-02-20
PCT/US1999/003703 WO1999042584A1 (en) 1998-02-20 1999-02-19 Apoptosis inducing molecule ii and methods of use

Publications (1)

Publication Number Publication Date
AU2972199A true AU2972199A (en) 1999-09-06

Family

ID=26702277

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29721/99A Abandoned AU2972199A (en) 1998-02-20 1999-02-19 Apoptosis inducing molecule ii and methods of use

Country Status (5)

Country Link
EP (1) EP1054968A1 (en)
JP (1) JP2002504333A (en)
AU (1) AU2972199A (en)
CA (1) CA2321186A1 (en)
WO (1) WO1999042584A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495520B2 (en) 1996-03-22 2002-12-17 Human Genome Sciences, Inc. Apoptosis Inducing Molecule II and methods of use
US6635743B1 (en) 1996-03-22 2003-10-21 Human Genome Sciences, Inc. Apoptosis inducing molecule II and methods of use
US7964190B2 (en) 1996-03-22 2011-06-21 Human Genome Sciences, Inc. Methods and compositions for decreasing T-cell activity
US6479254B2 (en) 1996-03-22 2002-11-12 Human Genome Sciences, Inc. Apoptosis inducing molecule II
US6140467A (en) * 1997-07-07 2000-10-31 La Jolla Institute For Allergy And Immunology Ligand for herpes simplex virus entry mediator and methods of use
US7118742B2 (en) 1997-07-07 2006-10-10 La Jolla Institute For Allergy And Immunology Ligand for herpes simplex virus entry mediator and methods of use
US6998108B1 (en) 1997-07-07 2006-02-14 La Jolla Institute For Allergy And Immunology Antibodies to p30 polypeptides and methods making and using same
JP2003528030A (en) * 1999-03-11 2003-09-24 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド Apoptosis-inducing molecule II
WO2001079496A2 (en) * 2000-03-13 2001-10-25 La Jolla Institute For Allergy And Immunology Ligand for herpes simplex virus entry mediator and methods of use
ES2352742T3 (en) * 2000-04-12 2011-02-22 La Jolla Institute For Allergy And Immunology BINDING FOR THE SIMPLE HERPES VIRUS INPUT MEDIATOR AND USE PROCEDURES.
EP1364653A4 (en) * 2001-02-23 2005-01-26 Takeda Pharmaceutical Casoase 3 inhibitors
WO2002066049A1 (en) * 2001-02-23 2002-08-29 Takeda Chemical Industries, Ltd. Agents for plasmic change
ES2643687T3 (en) 2006-08-28 2017-11-23 Kyowa Hakko Kirin Co., Ltd. HLIGHT antagonist-specific human monoclonal antibodies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100497017B1 (en) * 1996-03-22 2005-11-29 휴먼 게놈 사이언시즈, 인코포레이티드 Highly induced molecule II
DE69730607T2 (en) * 1996-07-19 2005-01-27 Takeda Chemical Industries, Ltd. FAS LIGAND SIMILAR PROTEIN, ITS MANUFACTURE AND USE
US6346388B1 (en) * 1997-08-13 2002-02-12 Smithkline Beecham Corporation Method of identifying agonist and antagonists for tumor necrosis related receptors TR1 and TR2
WO1999011662A1 (en) * 1997-09-05 1999-03-11 Millennium Biotherapeutics, Inc. Novel molecules of the tnfr-ligand-related protein family and uses thereof

Also Published As

Publication number Publication date
CA2321186A1 (en) 1999-08-26
JP2002504333A (en) 2002-02-12
EP1054968A1 (en) 2000-11-29
WO1999042584A9 (en) 1999-11-18
WO1999042584A1 (en) 1999-08-26

Similar Documents

Publication Publication Date Title
AU5711196A (en) Apoptosis inducing molecule i
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
AU7812998A (en) Versatile stereotactic device and methods of use
EP1018987A4 (en) Neocartilage and methods of use
AU1616499A (en) Chemokine variants and methods of use
AU8967998A (en) Antibiotic-ligand conjugates and methods of use thereof
AU3623700A (en) Apoptosis inducing molecule ii and methods of use
AU2972199A (en) Apoptosis inducing molecule ii and methods of use
AU3374699A (en) Methods of preparing and using electrostatically treated fluids
AU5923998A (en) 2-benzoylamino-3-phenylpropenamide derivatives and methods of using the same
AU3241895A (en) Apoptosis related protein bcl-y, and methods of use thereof
AU3118297A (en) Sok-1 and methods of use
AU1451200A (en) Dual reporter system and methods of use therefor
AU1126000A (en) Proliferation and apoptosis related proteins
AU2587399A (en) Human transport-associated molecules
AU6412599A (en) Oxybutynin formulations and methods of use
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
AU6582698A (en) Therapeutic uses of grip and grip-related molecules
AU5446499A (en) Apoptosis inducing agents
IL134210A0 (en) Use of transcription factor brn-3a
AU5131699A (en) Cryogranulation of activated protein c
AU4629399A (en) Substituted piperazones and their therapeutic uses
AU2588000A (en) Novel adhesion molecule and methods of use
AU2584699A (en) Immediate early genes and methods of use therefor
AU6084598A (en) Antibiotic-ligand conjugates and methods of use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase